NOTICES: National Institute of Mental Health,
Published: 2008-12-04
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Interagency Autism Coordinating Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign
NOTICES: Reclassification Petitions for Medical Devices,
Published: 2008-12-04
The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal agencies are required to publish notice in the
Federal Register concerning each proposed collection of information,
including each
Part II: Health and Human Services Department, Centers for Medicare & Medicaid Services,
Published: 2008-12-03
This final rule will implement provisions of section 6044 of
the Deficit Reduction Act of 2005, which amends the Social Security Act
by adding a new section 1937 related to the coverage of medical
assistance under approved State plans. It also provides States
increased flexibility under an approved State plan to define the scope
of covered medical
NOTICES: Submission of Patent Information for Certain Old Antibiotics; Draft Guidance for Industry,
Published: 2008-12-03
The Food and Drug Administration (FDA) is announcing the
availability of a draft guidance for industry entitled ``Submission of
Patent Information for Certain Old Antibiotics.'' The draft guidance
describes the agency's current thinking on the implementation of
certain provisions of the Q1 Program Supplemental Funding Act (the Q1
Act) that
NOTICES: National Institute of General Medical Sciences,
Published: 2008-12-03
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions
NOTICES: Hospital Inpatient Prospective Payment Systems and Fiscal Year 2009 Rates; Fiscal Year 2009 Wage Index Changes etc.,
Published: 2008-12-03
This notice contains fiscal year (FY) 2009 revised final wage
indices and hospital reclassifications for 27 hospitals. These revised
final wage indices and hospital reclassifications were made according
to special procedural rules set forth in the FY 2009 hospital inpatient
prospective payment systems final rule (73 FR 485889).
NOTICES: Agency Information Collection Activities; Proposals, Submissions, and Approvals,
Published: 2008-12-02
In compliance with the requirement for opportunity for public
comment on proposed data collection projects (section 3506(c)(2)(A) of
Title 44, United States Code, as amended by the Paperwork Reduction Act
of 1995, Public Law 10413), the Health Resources and Services
Administration (HRSA) publishes periodic summaries of proposed projects
being
NOTICES: Agency Information Collection Activities; Proposals, Submissions, and Approvals,
Published: 2008-12-02
Proposed Projects
Title: TANF Quarterly Financial Report, ACF196.
OMB No.: 09700247.
Description: The Tribal TANF Quarterly Financial Report provides
specific data regarding expenditures and provides a mechanism for
Tribes to request grant awards and certify the availability of State
matching funds. Failure to collect this data would
NOTICES: Agency Information Collection Activities; Proposals, Submissions, and Approvals,
Published: 2008-12-02
Periodically, the Health Resources and Services Administration
(HRSA) publishes abstracts of information collection requests under
review by the Office of Management and Budget (OMB), in compliance with
the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35). To request
a copy of the clearance requests submitted to OMB for review, email
NOTICES: Government-Owned Inventions; Availability for Licensing,
Published: 2008-12-02
The inventions listed below are owned by an agency of the U.S.
Government and are available for licensing in the U.S. in accordance
with 35 U.S.C. 207 to achieve expeditious commercialization of results
of federallyfunded research and development. Foreign patent
applications are filed on selected inventions to extend market coverage
for companies
NOTICES: Government-Owned Inventions; Availability for Licensing,
Published: 2008-12-02
The inventions listed below are owned by an agency of the U.S.
Government and are available for licensing in the U.S. in accordance
with 35 U.S.C. 207 to achieve expeditious commercialization of results
of federallyfunded research and development. Foreign patent
applications are filed on selected inventions to extend market coverage
for companies
NOTICES: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Transmission and Pathogenesis of HIV in Women,
Published: 2008-12-02
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the
NOTICES: Proposed Substances to be Evaluated for Set 23 Toxicological Profiles,
Published: 2008-12-02
This notice announces the list of proposed substances that
will be evaluated for CERCLA Set 23 toxicological profile development.
ATSDR's Division of Toxicology and Environmental Medicine is soliciting
public nominations from the list of proposed substances to be evaluated
for toxicological profile development. ATSDR also will consider the
NOTICES: Current List of Laboratories Which Meet Minimum Standards to Engage in Urine Drug Testing for Federal Agencies,
Published: 2008-12-02
The Department of Health and Human Services (HHS) notifies
Federal agencies of the laboratories currently certified to meet the
standards of Subpart C of the Mandatory Guidelines for Federal
Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory
Guidelines were first published in the Federal Register on April 11,
1988 (53 FR 11970),
NOTICES: Agency Information Collection Activities; Proposals, Submissions, and Approvals,
Published: 2008-12-02
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
NOTICES: Agency Information Collection Activities; Proposals, Submissions, and Approvals,
Published: 2008-12-02
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
NOTICES: Agency Information Collection Activities; Proposals, Submissions, and Approvals,
Published: 2008-12-02
Proposed Projects
Title: HHS/ACF/OPRE Head Start Classroombased Approaches and
Resources for Emotion and Social skill promotion (CARES) project: Impact and Implementation Studies.
OMB No.: New Collection.
Description: The Head Start Classroombased Approaches and
Resources for Emotion and Social skill promotion (CARES) project will
RULES: Ractopamine,
Published: 2008-12-01
The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect approval of a new animal drug application
(NADA) filed by Elanco Animal Health. The NADA provides for use of
ractopamine hydrochloride Type A medicated articles to make Type B and
Type C medicated feeds used for increased rate of weight gain and
improved feed
NOTICES: Data Retention When Subjects Withdraw from FDA-Regulated Clinical Trials,
Published: 2008-12-01
The Food and Drug Administration (FDA) is announcing the
availability of a guidance entitled ``Data Retention When Subjects
Withdraw from FDARegulated Clinical Trials.'' This guidance clarifies
FDA's position that it is critical that data be retained from trial
participants who decide to discontinue participation in a clinical
study of an
NOTICES: Agency Information Collection Activities; Proposals, Submissions, and Approvals,
Published: 2008-12-01
Periodically, the Substance Abuse and Mental Health Services
Administration (SAMHSA) will publish a summary of information
collection requests under OMB review, in compliance with the Paperwork
Reduction Act (44 U.S.C. Chapter 35). To request a copy of these
documents, call the SAMHSA Reports Clearance Officer on (240) 2761243.
Proposed
NOTICES: Center for Substance Abuse Prevention,
Published: 2008-12-01
Pursuant to Public Law 92463, notice is hereby given that the
Substance Abuse and Mental Health Services Administration's (SAMHSA)
Center for Substance Abuse Prevention (CSAP) National Advisory Council will meet on December 15, 2008, from 2 p.m. to 3 p.m. via
teleconference.
The meeting will include discussion and evaluation of grant
NOTICES: Center for Substance Abuse Treatment,
Published: 2008-12-01
Pursuant to Public Law 92463, notice is hereby given of the
meeting of the Center for Substance Abuse Treatment (CSAT) National Advisory Council on December 11, 2008.
The meeting is open to the public and will include discussion of
the Center's policy issues, and current administrative, legislative, and program developments.
Attendance
NOTICES: Agency Information Collection Activities; Proposals, Submissions, and Approvals,
Published: 2008-12-01
NOTICES: Draft Guidance on Important Considerations for When Participation of Human Subjects in Research is Discontinued,
Published: 2008-12-01
The Office for Human Research Protections (OHRP), Office of
Public Health and Science, is announcing the availability of a draft
guidance document entitled, ``Guidance on Important Considerations for
When Participation of Human Subjects in Research is Discontinued,'' and
is seeking comment on the draft guidance. The draft guidance document,
when
NOTICES: Agency Information Collection Activities; Proposals, Submissions, and Approvals,
Published: 2008-12-01
This notice announces the intention of the Agency for
Healthcare Research and Quality (AHRQ) to request that the Office of
Management and Budget (OMB) approve the proposed information collection
project: ``Colorado Regional Health Information Exchange (CORHIO)
Point of Care Exchange System Evaluation: Point of Care Questionnaires
and Focus
